N/A
Completed N=45
Impact of Pushrim Activated Power Assist Wheelchairs on Mobility Among People With Tetraplegia
Wheelchair Users
Source: ClinicalTrials.gov NCT00281463 ↗
Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Nov 2014
Primary outcomePrimary: Oxygen Consumption — 625 VO2 (ml/min)
Summary
The purpose of this three phase study is to evaluate a Pushrim Activated Power Assist Wheelchair (PAPAW). Phase I will examine whether the steady-state, metabolic energy efficiency for propelling a manual wheelchair with and without the device will be significantly different. In Phase II, wheelchair users will evaluate the PAPAW over activities of daily living course to determine its usability and acceptability and to identify areas for future development. Finally, in phase III, comparison of activities of daily living in the community will be made between the subjects when using their personal wheelchair and a PAPAW.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Oxygen Consumption |
415 | — |
Eligibility Criteria
Inclusion Criteria
- 18 and 65 years of age
- Full time wheelchair user
- Diagnosis of Tetraplegia
Exclusion Criteria
- Pressure sores
- Shoulder pain that would prevent them from propelling a manual wheelchair
- History of cardiopulmonary disease.
Data sourced from ClinicalTrials.gov (NCT00281463). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.